Previous Page  10 / 13 Next Page
Information
Show Menu
Previous Page 10 / 13 Next Page
Page Background

Volume 3

Journal of Nursing Research and Practice

Nursing and Heart 2019

April 22-23, 2019

Page 32

Notes:

Nursing Education and Evidence Based Practice Conference

Heart Conference

April 22-23, 2019 Dubai, UAE

World

4

th

International

&

Shade Akande, J Nursing Research and Practice, Volume 3

DOI: 10.4172/2632-251X-C3-007

Factors associated with heart failure readmissions from skilled nursing facilities

Background:

Despite guideline-driven pharmacological therapies and careful transitional care, the rates of preventable

hospital re-admission of heart failure patients and associated costs remain unacceptably high in the Skilled Nursing Facilities

(SNF) populations. Transfer to SNF is one strategy to limit hospitalizations. As such, 25% of patients are still symptomatic at

time of discharge.

Purpose:

The objective of this study is to identify patient factors affecting re-admissions of heart failure patients residing in

SNF within 30-days.

Methods:

A retrospective electronic chart review was completed on patients >65 years with heart failure who were admitted

into large medical center between 2012 and 2014. Descriptive statistics and univariate analyses using the chi-square test or

Fisher’s exact test for categorical variables and the Mann-Whitney test for continuous data was used to compare patients

readmitted within 30 days vs. those who were not readmitted within 30 days. Significant factors associated with readmission

in the univariate analysis (p<0.10) were included for a multivariate logistic regression model.

Results:

Fifteen variables: creatinine, weight difference, Chronic Kidney Disease (CKD), Angina, Arrhythmia, Valvular Heart

Disease (VHD), Tobacco, ADL, independent in bathing, independent in the toilet, S3 Heart sounds present, HJR, AF, Nitrates,

and Hydralazine, were identified for the multivariate logistic regression as potential risk factors associated with “readmission

within 30 days”. Creatinine and ADLs were included in the final model as this subset of predictors was found to be the best

for prediction of “readmission within 30 days”. Creatinine (p<0.0087) and ADLs (p<0.0077) were both significantly associated

with readmission within 30 days in the final logistic regression model. Every 1-unit increase in creatinine is associated with an

87% increase in the odds of being readmitted within 30 days (OR = 1.87). Those patients who require assistance with ADLs

are over 9 times more likely to be readmitted within 30 days (OR=9.25) as compared to patients who are independent.

Biography

Shade Akande’s philosophy of Nursing is grounded in quality and excellence in nursing practice with specific interest in the field of Cardiomyopathy. Her population of

interest being the older adult with heart failure residing in Nursing Homes, in the community, and at Skilled Nursing Facilities. Shade Akande’s wealth of knowledge, edu-

cational background both international and here in USA, coupled with evidence-based research will equip me with delivering outstanding care with positive outcome. As PI

and co-investigators in NIH funded and multi-center research, she engages in inquiry that may assist with evidence-based practice. she has also engaged in both didactic

and clinical teaching to Nurse Practitioner students and as mentors to Doctoral of Nursing Practice (DNP) students. As a clinician, she has the expertise, leadership and

motivation to successfully contribute to the mission and values of programs and the institution as a whole. Shade Akande is aware of importance of frequent communica-

tion among the project leaders, interdisciplinary team with construction of realistic plan and timeline. She plans to consistently and continually deliver excellent and quality

care to the population with increased productivity and positive outcome, to foster unity and dedication to excellence, fostering education and to embrace the concept of

continuous performance improvement.

fjadesola@aol.com

Shade Akande

CB Medical Inc., USA